A Case of Clozapine Toxicity Caused by Infection in a Patient with Treatment-Resistant Schizophrenia
Abstract
Background: Clozapine is an effective antipsychotic for the treatment of treatment-resistant schizophrenia, but its use is associated with a risk of serious adverse events, especially when plasma levels of the drug exceed the therapeutic reference range. Infections have been reported to contribute to clozapine toxicity, although the underlying mechanisms remain incompletely understood.
Case presentation: We report the case of a woman in her seventies with treatment-resistant schizophrenia who developed clozapine intoxication, with plasma levels exceeding 3000 ng/mL, following an infectious episode. The patient had been receiving clozapine (300 mg/day) for one year without adverse effects. However, she developed fatigue and severe motor impairment and was found to have elevated levels of inflammatory markers and multiple infectious sources, including a pulmonary abscess, a pelvic abscess, and a decubitus ulcer. Upon admission, her plasma clozapine level was 3085 ng/mL. No changes in concomitant medications were identified, and the electrocardiography (ECG) findings were unremarkable. With antibiotic therapy and a gradual reduction in clozapine dose, her plasma levels reduced, and her symptoms were alleviated. She was discharged after 18 weeks of hospitalization.
Conclusion: This case highlights the potential for infection-induced clozapine intoxication even at relatively moderate doses of the drug. Regular monitoring of clozapine plasma levels is critical for the early…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.